Correction to: The Role of H2S in Atherosclerosis and Associated Cardiometabolic Comorbidities [0.03%]
Correction to：H2S在动脉粥样硬化及相关的代谢共病中的作用
Odysseia Savvoulidou,Turtushikh Damba,Daniel F J Ketelhuth et al.
Odysseia Savvoulidou et al.
Published Erratum
Handbook of experimental pharmacology. 2026:292:273-274. DOI:10.1007/164_2026_795 2026
John Hogwood,Elaine Gray
John Hogwood
Antithrombotic and antiplatelet agents have been in use for over 100 years, with many listed as WHO essential medicines. Mortality and morbidity caused by cardiovascular diseases and due to arterial and venous thrombosis are increasing glob...
Role of Innate Immune Receptors in Cardiac Damage Linked to Metabolic Disorders [0.03%]
固有免疫受体在代谢性疾病相关心脏损伤中的作用
Almudena Val-Blasco,Marta Gil-Fernández,Andrea Bueno-Sen et al.
Almudena Val-Blasco et al.
This chapter underscores the pivotal role of immune receptors, particularly Toll-like receptors (TLRs) and NOD-like receptors (NLRs), in the intricate interplay between metabolic diseases and their associated cardiovascular comorbidities. T...
Avelino-Cruz José Everardo,Yang-Bennett Daniela Sarahi,Galindo-Ramírez Fabián
Avelino-Cruz José Everardo
The contractile activity of the heart depends on the coordinated activation of cardiac muscle cells, as well as the activation of each region within these cells. The conversion of an electrical signal into a mechanical process is known as e...
Physiological Roles of Hydrogen Sulfide/Polysulfides and Regulation of their Production [0.03%]
氢硫酸/多硫化物的生理功能及其产生机制的调节
Hideo Kimura
Hideo Kimura
Hydrogen sulfide (H2S), produced enzymatically, acts as a signaling molecule involved in the regulation of neurotransmission, vascular tone, cytoprotection, inflammation, oxygen sensing, and energy metabolism. Hydrogen polysulfides (H2Sn, n...
Oxidative Modifications in Cardiac Mitochondrial and Ca2+ Handling Proteins in Obesity and Metabolic Syndrome: Antioxidant Alternatives [0.03%]
肥胖和代谢综合征中心肌线粒体和钙离子处理蛋白的氧化修饰：抗氧化替代品
Karla Carvajal,David Julian Arias-Chávez,Patrick Mailloux-Salinas et al.
Karla Carvajal et al.
Obesity and its related comorbidities, collectively defined as metabolic syndrome (MetS), represent a major health concern due to their strong association with increased cardiometabolic risk. A defining feature of obesity and MetS is the ex...
Myrian Velasco,Alondra Albarado-Ibañez,Carlos Larqué et al.
Myrian Velasco et al.
Anatomical and physiological differences between sexes explain the sexual dimorphism in the development of diseases, such as obesity and metabolic syndrome. This syndrome is a condition that increases the risk of developing cardiovascular d...
J Gustavo Vázquez-Jiménez,Tatiana Romero-García
J Gustavo Vázquez-Jiménez
The significant concern about the incidence and prevalence of cardiometabolic disorders around the world continues to rise as this upward trend persists. As researchers intensify their search for underlying causes, there is a growing demand...
In Search of a Biomarker for Vasculopathy Associated with Metabolic Syndrome [0.03%]
寻找与代谢综合征相关的血管病生物标志物之旅
Donjuán-Loredo Guadalupe,Saavedra-Serrato Luis,Chávez-Morales Tómas et al.
Donjuán-Loredo Guadalupe et al.
Central obesity is associated with a group of metabolic and cardiovascular alterations known as metabolic syndrome (MetS). MetS affects an estimated 20-25% of the global population. The clinical diagnosis of MetS is made using different met...
Are the Direct Oral Anticoagulants Better Than Warfarin for the Prevention and Treatment of Stroke and Atrial Fibrillation? [0.03%]
直接口服抗凝药物较华法林更有优势用于预防和治疗卒中及相关房颤吗？
Vittorio Pengo,Francesco Marongiu,Doris Barcellona
Vittorio Pengo
Atrial fibrillation is the most common cardiac arrhythmia in adults, affecting approximately 59.7 million people worldwide as of 2019-a 111% increase since 1990. Over the past 20 years, the prevalence of AF has risen by 33%, and it is proje...